GlobeNewswire Inc.··NaWHO Backs Regeneron's Ebola Antibody for Bundibugyo Outbreak Trial
WHO recommends Regeneron's maftivimab for clinical trials against Bundibugyo ebolavirus outbreak in Democratic Republic of Congo and Uganda.
REGNclinical trialsmonoclonal antibodies